Back
AbbVie Vs. Nike Industry Stock Comparison
Buy
60
ABBV
AbbVie
Last Price:
165.98
Seasonality Move:
-0.67%
Sell
17
NKE
Nike
Last Price:
76.06
Seasonality Move:
6.25%
Buy
60
AbbVie (ABBV)
is a Buy
Is AbbVie a Buy, Sell or Hold?
- The current AbbVie [ABBV] share price is $170.37. The Score for ABBV is 60, which is 20% above its historic median score of 50, and infers lower risk than normal.
- ABBV is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
17
Nike (NKE)
is a Sell
Is Nike a Buy, Sell or Hold?
- The current Nike [NKE] share price is $76.83. The Score for NKE is 17, which is 66% below its historic median score of 50, and infers higher risk than normal.
- NKE is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk could be especially high.
ABBV Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 1.96 | Buy |
Relative Strength Index (14 RSI): | 55.85 | Buy |
Chaikin Money Flow: | -3002903 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (160.77 - 171.95) | Buy |
Bollinger Bands (100): | (162.7 - 177.46) | Buy |
NKE Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -2.29 | Sell |
Relative Strength Index (14 RSI): | 22.31 | Sell |
Chaikin Money Flow: | 35382688 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (87.89 - 98.33) | Sell |
Bollinger Bands (100): | (90.25 - 101.25) | Sell |
ABBV Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 171.01 | Sell |
20-day SMA: | 168.71 | Buy |
50-day SMA: | 164.75 | Buy |
200-day SMA: | 160.7 | Buy |
8-day EMA: | 170.43 | Sell |
20-day EMA: | 168.58 | Buy |
50-day EMA: | 167.03 | Buy |
200-day EMA: | 162.23 | Buy |
NKE Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 90.64 | Sell |
20-day SMA: | 93.19 | Sell |
50-day SMA: | 92.98 | Sell |
200-day SMA: | 100.11 | Sell |
8-day EMA: | 87.55 | Sell |
20-day EMA: | 91.33 | Sell |
50-day EMA: | 93.16 | Sell |
200-day EMA: | 99.5 | Sell |
AbbVie Earnings Growth & ABBV Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.04 per share, an increase next quarter of $0.21 per share, an increase this year of $0.11 per share, and an increase next year of $0.82 per share.
Nike Earnings Growth & NKE Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.01 per share, a decrease next quarter of $0.13 per share, an increase this year of $0.48 per share, and a decrease next year of $0.40 per share.
AbbVie Technical Analysis
Jun 17 | Jun 18 | Jun 20 | Jun 21 | Jun 24 | Jun 25 | Jun 26 | Jun 27 | Jun 28 | Jul 1 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | ||||||||||
17 | 18 | 20 | 21 | 24 | 25 | 26 | 27 | 28 | 01 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Nike Technical Analysis
Jun 17 | Jun 18 | Jun 20 | Jun 21 | Jun 24 | Jun 25 | Jun 26 | Jun 27 | Jun 28 | Jul 1 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | ||||||||||
17 | 18 | 20 | 21 | 24 | 25 | 26 | 27 | 28 | 01 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |